Who
Nathaniel A. Grawey
Chief Commercial Officer
Company insider
Files Form 4 as: Chief Commercial Officer, Tenon Medical.
In numbers
- Trades disclosed
- 4
- Buys
- 1
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 14 Nov 2025
- Last trade
- 1 May 2026
- Last filed
- 5 May 2026
Companies traded
Activity over time
1 Nov 2025 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 1 May 2026filed 5 May 2026 | TNON Tenon MedicalMedical Devices | SEC FORM 4 Code A | —68,201 at $0.00 | filing |
| 1 May 2026filed 5 May 2026 | TNON Tenon MedicalMedical Devices | SEC FORM 4 Code A | —68,201 at $0.00 | filing |
| 14 Nov 2025filed 18 Nov 2025 | TNON Tenon Medicaloption or derivative · Medical Devices | SEC FORM 4 Code P | —101,167 | filing |
| 14 Nov 2025filed 18 Nov 2025 | TNON Tenon MedicalMedical Devices | SEC FORM 4 Bought | —101,167 | filing |
News
Financial Analysis: Tenon Medical (NASDAQ:TNON) vs. Coloplast A/S (OTCMKTS:CLPBY)TNON · dailypolitical.com · 23 Oct 2026Tenon Medical Adds Eight New Patents Issued by the United States Patent and Trademark Office Through Q3 2026TNON · finanznachrichten.de · 15 Oct 2026
0 headlines in the last 90 days name Nathaniel A. Grawey; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.